+1 888-880-9539Search News by Tag: mRNA
50 news stories found
Press Release
April 24, 2026
Creative Biolabs announced the launch of its enhanced lipid nanoparticle (LNP) conjugation platform—solving long‑standing challenges in nucleic acid delivery for gene therapy and RNA‑based therapeutics.
Read Press Release
Press Release
April 16, 2026
Creative Biolabs' webinar on May 19, 2026, explores optimized lipid nanoparticles to improve CRISPR‑Cas9 delivery efficiency and enhance gene‑editing outcomes in lung tumor models.
Read Press Release
Press Release
March 20, 2026
CD BioSciences unveiled a full range of one-stop biofilm imaging services, designed to meet the diverse scientific research needs of the global life science community in the study of biofilm structure, function, and dynamics.
Read Press Release
Press Release
March 13, 2026
Creative Biolabs, a leading global biotechnology service provider, today detailed its expanded technological capabilities in non-vaccine mRNA applications.
Read Press Release
Press Release
March 12, 2026
Andrea Maria Femino, PhD, shares her professional achievements and industry expertise in Fortune magazine
Read Press Release
Press Release
December 4, 2025
High-resolution inline monitoring for chromatography, filtration, and API workflows
Read Press Release
Press Release
November 30, 2025
Creative Biogene recently announced the release of its custom RNA services set the foundation for successful transforming cutting-edge scientific discoveries into industry-grade tools and service capabilities.
Read Press Release
Press Release
November 21, 2025
Creative Biolabs launches an advanced mRNA platform integrating in silico structural prediction and polymer-based delivery development to accelerate mRNA therapeutics and iPSC reprogramming.
Read Press Release
Press Release
November 20, 2025
Creative Biolabs has introduced an all-in-one LNP product to simplify and accelerate precision delivery for genetic medicines like mRNA and gene editing.
Read Press Release
Press Release
September 19, 2025
Thomas Murphy, PhD, has been endorsed by Marquis Who's Who as a leader in the energy and chemical industries
Read Press Release
Press Release
September 19, 2025
Creative Biolabs has unparalleled experience in immunotherapy modeling and offers a full suite of services that address every facet of CAR-T development.
Read Press Release
Press Release
July 24, 2025
James "Jim" G. Stout, PhD, is a distinguished leader with 25 years of experience in the biotechnology industry
Read Press Release
Press Release
July 9, 2025
With more than a decade of experience, Creative Biolabs provides one-stop liposome formulation and large-scale manufacture, customized to respond to the constantly changing drug development requirements.
Read Press Release
Press Release
June 24, 2025
With mRNA's star power surging from vaccines to gene therapy to precision medicine, the biotech innovator Creative Biolabs is unlocking next-gen solutions to fast-track "impossible" medical breakthroughs.
Read Press Release
Press Release
June 10, 2025
Health Freedom Advocate Submits Legal Notice to HHS, NIH, and DOJ Calling for Investigation into COVID-19 Origins and Related Research Practices
Read Press Release
Press Release
May 22, 2025
Global CRO service provider Creative Biolabs has enhanced its extracellular vesicle platform with recent advancements in exosome isolation, characterization, and RNA sequencing.
Read Press Release
Press Release
March 27, 2025
Creative Biolabs is a pioneer in innovation, offering cutting-edge technologies and expertise to facilitate the development of effective monkeypox vaccines.
Read Press Release
Press Release
March 4, 2025
Unraveling stress granules: key to understanding neurodegenerative diseases
Read Press Release
Press Release
December 30, 2024
30-Year Lab Virus Vaccine Veteran Presents Sworn Documents in Video Evidencing COVID-19's Bioweaponization from HIV-1/AIDS.
Read Press Release
Press Release
December 24, 2024
The author summarized the traditional and emerging methods for circRNA detection as well as the advantages and limitations, and look forward to future research directions.
Read Press Release